{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T18:32:48Z","timestamp":1772908368952,"version":"3.50.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T00:00:00Z","timestamp":1543449600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001635","name":"University of Limerick","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001635","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12913-018-3717-2","type":"journal-article","created":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T09:38:48Z","timestamp":1543484328000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Barriers to progressing through a methadone maintenance treatment programme: perspectives of the clients in the Mid-West of Ireland\u2019s drug and alcohol services"],"prefix":"10.1186","volume":"18","author":[{"given":"Lisa","family":"Moran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eamon","family":"Keenan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8652-1867","authenticated-orcid":false,"given":"Khalifa","family":"Elmusharaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,29]]},"reference":[{"issue":"1","key":"3717_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/ajad.12317","volume":"25","author":"J Teoh Bing Fei","year":"2016","unstructured":"Teoh Bing Fei J, Yee A, Habil MH. Psychiatric comorbidity among patients on methadone maintenance therapy and its influence on quality of life. Am J Addict. 2016;25(1):49\u201355.","journal-title":"Am J Addict"},{"key":"3717_CR2","unstructured":"United Nations Office on Drugs and Crime. World drug report 2018 (United Nations publication, Sales No. E.18.XI.9). [\n                    https:\/\/www.unodc.org\/wdr2018\/\n                    \n                  ]."},{"issue":"1","key":"3717_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/dar.12088","volume":"33","author":"LWH Degenhardt","year":"2014","unstructured":"Degenhardt LWH, Hall WD. The global burden of disease projects: what have we learned about illicit drug use and dependence and their contribution to the global burden of disease? Drug Alcohol Rev. 2014;33(1):4\u201312.","journal-title":"Drug Alcohol Rev"},{"key":"3717_CR4","unstructured":"United Nations Office on Drugs and Crime. Executive summary, conclusions and policy implications. World drug report 2018 (United Nations publication, Sales No. E.18.XI.9) [\n                    https:\/\/www.unodc.org\/wdr2018\/prelaunch\/WDR18_Booklet_1_EXSUM.pdf\n                    \n                  ]."},{"key":"3717_CR5","first-page":"1","volume":"6","author":"M Soyka","year":"2015","unstructured":"Soyka M. New developments in the management of opioid dependence: focus on sublingual buprenorphine-naloxone. Subst Abus Rehabil. 2015;6:1\u201314.","journal-title":"Subst Abus Rehabil"},{"key":"3717_CR6","unstructured":"European Drug Report 2016: Trends and Developments [\n                    http:\/\/www.emcdda.europa.eu\/publications\/edr\/trends-developments\/2016_en\n                    \n                  ]."},{"key":"3717_CR7","volume-title":"Prevalence of opiate use in Ireland 2006. A 3-source capture recapture study. In","author":"A Kelly","year":"2009","unstructured":"Kelly A, Teljeur C, Carvalho M. Prevalence of opiate use in Ireland 2006. A 3-source capture recapture study. In. Dublin: Trinity College Dublin; 2009."},{"key":"3717_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.amjmed.2014.07.043","volume":"128","author":"SW John Kelly","year":"2015","unstructured":"John Kelly SW, Sailtz R. Stop talking 'dirty'; clinicians, language and the quality of care for the leading cause of preventable death in the United States. Am J Med. 2015;128:8\u20139.","journal-title":"Am J Med"},{"issue":"1","key":"3717_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12939-018-0732-1","volume":"17","author":"P O\u2019Donnell","year":"2018","unstructured":"O\u2019Donnell P, O\u2019Donovan D, Elmusharaf K. Measuring social exclusion in healthcare settings: a scoping review. Int J Equity Health. 2018;17(1):15.","journal-title":"Int J Equity Health"},{"issue":"1","key":"3717_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/ADM.0000000000000275","volume":"11","author":"S Wakeman","year":"2017","unstructured":"Wakeman S. Medications for addiction treatment: changing the language to improve care. J Addict Med. 2017;11(1):1\u20132.","journal-title":"J Addict Med"},{"issue":"4","key":"3717_CR11","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1056\/NEJMra1604339","volume":"375","author":"MA Schuckit","year":"2016","unstructured":"Schuckit MA. Treatment of opioid-use disorders. N Engl J Med. 2016;375(4):357\u201368.","journal-title":"N Engl J Med"},{"issue":"11","key":"3717_CR12","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1517\/14656560903037168","volume":"10","author":"A Stotts","year":"2009","unstructured":"Stotts A, Dodrill C, Kosten T. Opioid dependence treatment: options in pharmacotherapy. Expert Opin Pharmacother. 2009;10(11):1727\u201340.","journal-title":"Expert Opin Pharmacother"},{"key":"3717_CR13","unstructured":"MI LJH, Joseph H, Langrod J, Salsitz EA, Payte JT, Dole VP. Substance abuse: a comprehensive textbook. Fourth ed. Philadelphia: Lippincott Williams & Wilkins; 2006."},{"issue":"8","key":"3717_CR14","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1001\/jama.1965.03090080008002","volume":"193","author":"VP Dole","year":"1965","unstructured":"Dole VP, Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction: a clinical trial with methadone hydrochloride. Jama. 1965;193(8):646\u201350.","journal-title":"Jama"},{"key":"3717_CR15","first-page":"1","volume":"3","author":"R Mattick","year":"2009","unstructured":"Mattick R. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009;3:1\u201335.","journal-title":"Cochrane Database Syst Rev"},{"key":"3717_CR16","doi-asserted-by":"crossref","unstructured":"Mattick R. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;2.","DOI":"10.1002\/14651858.CD002207.pub4"},{"key":"3717_CR17","first-page":"e1229","volume":"2","author":"P Karki","year":"2016","unstructured":"Karki P, Shrestha R, Huedo-Medina TB, Copenhaver M. The impact of methadone maintenance treatment on HIV risk behaviors among high-risk injection drug users: a systematic review. Evid Based Med Public Health. 2016;2:e1229.","journal-title":"Evid Based Med Public Health"},{"key":"3717_CR18","doi-asserted-by":"crossref","unstructured":"Alavian SM, Mirahmadizadeh A, Javanbakht M, Keshtkaran A, Heidari A, Mashayekhi A, Salimi S, Hadian M. Effectiveness of methadone maintenance treatment in prevention of hepatitis C virus transmission among injecting drug users. Hepat Mon. 2013;13(8).","DOI":"10.5812\/hepatmon.12411"},{"key":"3717_CR19","doi-asserted-by":"crossref","unstructured":"Sordo LBG, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, Ferri M, Pastor-Barriuso R. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357.","DOI":"10.1136\/bmj.j1550"},{"issue":"1190","key":"3717_CR20","first-page":"U795","volume":"117","author":"I Sheerin","year":"2004","unstructured":"Sheerin I. Reduction in crime by drug users on a methadone maintenance therapy programme in New Zealand. N Z Med J. 2004;117(1190):U795.","journal-title":"N Z Med J"},{"key":"3717_CR21","doi-asserted-by":"crossref","unstructured":"Sun H-M, Li X-Y, Chow EPF, Li T, Xian Y, Lu Y-H, Tian T, Zhuang X, Zhang L. Methadone maintenance treatment programme reduces criminal activity and improves social well-being of drug users in China: a systematic review and meta-analysis. BMJ Open. 2015;5(1):e005997.","DOI":"10.1136\/bmjopen-2014-005997"},{"key":"3717_CR22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jsat.2016.07.006","volume":"69","author":"JYA Teoh Bing Fei","year":"2016","unstructured":"Teoh Bing Fei JYA, Habil MH, Danaee M. Effectiveness of methadone maintenance therapy and improvement in quality of life following a decade of implementation. J Subst Abus Treat. 2016;69:50\u20136.","journal-title":"J Subst Abus Treat"},{"key":"3717_CR23","unstructured":"Department of Health. Central Treatment List: Summary Report for HSE Mid-West Clinic. January 2016-Dec 2016 inclusive. In.: Health Service Executive 2016."},{"issue":"11","key":"3717_CR24","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1111\/j.1360-0443.2005.01230.x","volume":"100","author":"J Neale","year":"2005","unstructured":"Neale J, Allen D, Coombes L. Qualitative research methods within the addictions. Addiction. 2005;100(11):1584\u201393.","journal-title":"Addiction"},{"issue":"1","key":"3717_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.drugpo.2008.07.004","volume":"21","author":"JA Peterson RPS","year":"2010","unstructured":"Peterson RPS JA, Mitchell SG, Reisinger HS, Kelly SM, O\u2019Grady KE, Brown BS, Agar MH. Why don\u2019t out-of-treatment individuals enter methadone treatment programs? Int J Drug Policy. 2010;21(1):36\u201342.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"3717_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/02791072.2011.587392","volume":"43","author":"SGMR Mitchell","year":"2011","unstructured":"Mitchell SGMR, Reisinger HS, Peterson JA, Kelly SM, Agar MH, Brown BS, O'Grady KE, Schwartz RP. Redefining retention: recovery from the patient's perspective. J Psychoactive Drugs. 2011;43(2):99\u2013107.","journal-title":"J Psychoactive Drugs"},{"issue":"3","key":"3717_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/soc6030027","volume":"6","author":"SH Katrina Warren","year":"2016","unstructured":"Katrina Warren SH, Magalh\u00e3es L, Evans M. Exploring the daily lives of people on methadone maintenance treatment: an occupational perspective. Societies. 2016;6(3):27.","journal-title":"Societies"},{"issue":"1","key":"3717_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13011-015-0031-4","volume":"10","author":"A Granerud","year":"2015","unstructured":"Granerud A, Toft H. Opioid dependency rehabilitation with the opioid maintenance treatment programme-a qualitative study from the clients\u2019 perspective. Subst Abuse Treat Prev Policy. 2015;10(1):1.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"5","key":"3717_CR29","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.drugpo.2010.01.010","volume":"21","author":"J De Maeyer","year":"2010","unstructured":"De Maeyer J, Vanderplasschen W, Broekaert E. Quality of life among opiate-dependent individuals: a review of the literature. Int J Drug Policy. 2010;21(5):364\u201380.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"3717_CR30","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3109\/00952991003736371","volume":"36","author":"SM Kelly","year":"2010","unstructured":"Kelly SM, O\u2019Grady KE, Brown BS, Mitchell SG, Schwartz RP. The role of patient satisfaction in methadone treatment. Am J Drug Alcohol Abuse. 2010;36(3):150\u20134.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"4","key":"3717_CR31","first-page":"276","volume":"18","author":"A King","year":"2011","unstructured":"King A. Service user involvement in methadone maintenance programmes: the \u2018philosophy, the ideal and the reality. Drugs: Educ Prev Policy. 2011;18(4):276\u201380.","journal-title":"Drugs: Educ Prev Policy"},{"issue":"3","key":"3717_CR32","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1017\/S0790966700017171","volume":"29","author":"L Latham","year":"2012","unstructured":"Latham L. Methadone treatment in Irish general practice: voices of service users. Ir J Psychol Med. 2012;29(3):147\u201356.","journal-title":"Ir J Psychol Med"},{"key":"3717_CR33","volume-title":"Approaches to social enquiry: advancing knowledge, 2nd edn: polity","author":"N Blaikie","year":"2007","unstructured":"Blaikie N. Approaches to social enquiry: advancing knowledge, 2nd edn: polity; 2007."},{"key":"3717_CR34","unstructured":"Central Treatment List H: Central Treatment List Summary Report for HSE Mid-West Clinic. January 2016-Dec 2016 inclusive. In.: Health Service Executive; 2016."},{"issue":"2","key":"3717_CR35","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qual Res Psychol"},{"issue":"4","key":"3717_CR36","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0749-3797(98)00017-8","volume":"14","author":"V Felitti","year":"1998","unstructured":"Felitti V, Anda R, Nordenberg D. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. Am J Prev Med. 1998;14(4):245\u201358.","journal-title":"Am J Prev Med"},{"key":"3717_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-12-72","volume":"12","author":"M Bellis","year":"2014","unstructured":"Bellis M, Hughes K, Leckenby N, Perkins C, Lowey H. National Household Survey of adverse childhood experiences and their relationship with resilience to health-harming behaviours in England. BMC Med. 2014;12:72.","journal-title":"BMC Med"},{"issue":"3","key":"3717_CR38","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1542\/peds.111.3.564","volume":"111","author":"S Dube","year":"2003","unstructured":"Dube S, Felitti V, Dong M. Childhood abuse, neglect, and household dysfunction and the risk of illicit drug use: the adverse childhood experiences study. Pediatrics. 2003;111(3):564\u201372.","journal-title":"Pediatrics"},{"key":"3717_CR39","volume-title":"Adverse childhood experience and their impact on health-harming behaviours in the welsh adult population","author":"M Bellis","year":"2015","unstructured":"Bellis M, Ashton K, Hughes K, Ford K. Adverse childhood experience and their impact on health-harming behaviours in the welsh adult population. Wales: Liverpool John Moores University; 2015."},{"issue":"4","key":"3717_CR40","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0749-3797(98)00017-8","volume":"14","author":"V Felitti","year":"1998","unstructured":"Felitti V, Robert A, Nordenberg D, Williamson D. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. Am J Prev Med. 1998;14(4):245\u201358.","journal-title":"Am J Prev Med"},{"issue":"6","key":"3717_CR41","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.chiabu.2005.12.005","volume":"30","author":"L Renner","year":"2006","unstructured":"Renner L, Slack K. Intimate partner violence and child maltreatment: understanding intra- and intergenerational connections. Child Abuse Negl. 2006;30(6):599\u2013617.","journal-title":"Child Abuse Negl"},{"key":"3717_CR42","volume-title":"World Health Organization","author":"M Bellis","year":"2013","unstructured":"Bellis M, Hughes K, Gilbert R, Mitis F, Galea G. European report on preventing child maltreatment. In: World Health Organization; 2013."},{"issue":"1","key":"3717_CR43","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12887-018-1137-4","volume":"18","author":"BP Smyth","year":"2018","unstructured":"Smyth BP, Elmusharaf K, Cullen W. Opioid substitution treatment and heroin dependent adolescents: reductions in heroin use and treatment retention over twelve months. BMC Pediatr. 2018;18(1):151.","journal-title":"BMC Pediatr"},{"key":"3717_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2470547017698140","volume":"1","author":"L Kwako","year":"2017","unstructured":"Kwako L, Koob G. Neuroclinical framework for the role of stress in addiction. Chronic Stress. 2017;1:1\u201314.","journal-title":"Chronic Stress"},{"issue":"1","key":"3717_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.physbeh.2011.08.019","volume":"106","author":"A Danese","year":"2012","unstructured":"Danese A, McEwen B. Adverse childhood experiences, allostasis, allostatic load, and age-related disease. Physiol Behav. 2012;106(1):29\u201339.","journal-title":"Physiol Behav"},{"issue":"3","key":"3717_CR46","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/da.10015","volume":"15","author":"DJ Newport","year":"2002","unstructured":"Newport DJ, Wagner D, Wilcox M. The role of early adverse experience and adulthood stress in the prediction of neuroendocrine stress reactivity in women: a multiple regression analysis. Depress Anxiety. 2002;15(3):117\u201325.","journal-title":"Depress Anxiety"},{"key":"3717_CR47","unstructured":"Mat\u00e9 G. In the realm of hungry ghosts. Toronto: Vintage Canada; 2008"},{"key":"3717_CR48","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ejphar.2014.11.044","volume":"753","author":"GF Koob","year":"2015","unstructured":"Koob GF. The dark side of emotion: the addiction perspective. Eur J Pharmacol. 2015;753:73\u201387.","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"3717_CR49","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.biopsych.2013.01.032","volume":"73","author":"R Sinha","year":"2013","unstructured":"Sinha R, Jastreboff A. Stress as a common risk factor for obesity and addiction. Biol Psychiatry. 2013;73(9):827\u201335.","journal-title":"Biol Psychiatry"},{"key":"3717_CR50","volume-title":"An information manual","author":"Dept of Health","year":"2002","unstructured":"Dept of Health. Co-existing problems of mental disorder and substance misuse (dual diagnosis). In: An information manual; 2002."},{"issue":"1\u20132","key":"3717_CR51","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.drugalcdep.2009.01.019","volume":"103","author":"S Martins","year":"2009","unstructured":"Martins S, Keyes K, Storr C, Zhu H, Chilcoat H. Pathways between nonmedical opioid use\/dependence and psychiatric disorders: results from the National Epidemiologic Survey on alcohol and related conditions. Drug Alcohol Depend. 2009;103(1\u20132):16\u201324.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"3717_CR52","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.pain.2007.02.014","volume":"129","author":"M Edlund","year":"2007","unstructured":"Edlund M, Steffick D, Hudson T, Harris K. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain. 2007;129(3):355\u201362.","journal-title":"Pain"},{"key":"3717_CR53","unstructured":"Salloum I. Issues in Dual Diagnosis. Medscape. 2005. \n                    https:\/\/www.medscape.org\/viewarticle\/507192\n                    \n                  ."},{"key":"3717_CR54","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.2147\/NDT.S129480","volume":"13","author":"T Rosic","year":"2017","unstructured":"Rosic T, Naji L, Bawor M, Dennis B, Platter C. The impact of comorbid psychiatric disorders on methadone maintenance treatment in opioid use disorder: a prospective cohort study. Neuropsychiatr Dis Treat. 2017;13:1399\u2013408.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"3717_CR55","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13722-017-0074-0","volume":"12","author":"L Naji","year":"2017","unstructured":"Naji L, Dennis B, Bawor M, Varenbut M, Daiter J. The association between age of onset of opioid use and comorbidity among opioid dependent patients receiving methadone maintenance therapy. Addict Sci Clin Pract. 2017;12:9.","journal-title":"Addict Sci Clin Pract"},{"issue":"1","key":"3717_CR56","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1151\/spp021113","volume":"1","author":"T Kosten","year":"2002","unstructured":"Kosten T, George T. The neurobiology of opioid dependence: implications for treatment. Sci Pract Perspect. 2002;1(1):13\u201320.","journal-title":"Sci Pract Perspect"},{"key":"3717_CR57","volume-title":"The principles and Practive of methadone treatment European opiate addiction treatment association","author":"I Maremmani","year":"2009","unstructured":"Maremmani I. The principles and Practive of methadone treatment European opiate addiction treatment association; 2009."},{"issue":"11\u201312","key":"3717_CR58","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.3109\/10826088509047261","volume":"20","author":"DLD Hunt","year":"1985","unstructured":"Hunt DLD, Goldsmith DS. \u201cIt takes your heart\u201d: the image of methadone maintenance in the addict world and the effect on recruitment into treatment. Int J Addict. 1985;20(11\u201312):1751\u2013171.","journal-title":"Int J Addict"},{"key":"3717_CR59","volume-title":"Recovery orientated methadone maintenance. In","author":"W White","year":"2010","unstructured":"White W, Torres L. Recovery orientated methadone maintenance. In. Philadelphia: Great Lakes Addiction Technology Transfer Center, the Philadelphia Department of Behavioral Health and Mental Retardation Services, and the Northeast Addiction Technology Transfer Center; 2010."}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-018-3717-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12913-018-3717-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-018-3717-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T19:20:24Z","timestamp":1574968824000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-018-3717-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,29]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3717"],"URL":"https:\/\/doi.org\/10.1186\/s12913-018-3717-2","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,29]]},"assertion":[{"value":"15 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Lisa Moran is both a Senior Lecturer in Clinical and Communication Skills at Graduate Entry Medical School GEMS at University of Limerick and a GP working in the acute level 2 clinical setting of the Irish Mid-West Drug and Alcohol Services. Eamon Keenan is a Consultant Psychiatrist in Substance Misuse at HSE, Social Inclusion Office, Primary Care Division, Dublin \u2013 Ireland. Khalifa Elmusharaf is a Senior Lecturer in Public Health at Graduate Entry Medical School GEMS at University of Limerick.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"Ethical approval to undertake this study was granted by University Hospital Limerick\u2019s research ethics committee. Each participant signed a consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicting interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"911"}}